embecta to Report Fiscal First Quarter Financial Results
embecta (Nasdaq: EMBC) will report fiscal first quarter 2026 results and host a conference call on Thursday, February 5, 2026 at 8:00 a.m. ET.
Rhea-AI Summary
embecta (Nasdaq: EMBC) will report fiscal first quarter 2026 results and host a conference call on Thursday, February 5, 2026 at 8:00 a.m. ET. The call will include an operational update and a Q&A session. Investors can access a live webcast or teleconference, and a webcast replay will be available beginning at 11:00 a.m. ET on February 5, 2026 and archived on the embecta investor relations website for one year.
Details
News Market Reaction – EMBC
On Jan 23, the first trading day after this news, EMBC closed 9.44% below the previous close.
Data tracked by StockTitan Argus for the Jan 23 session.
Key Figures
- Earnings call time
- 8:00 a.m. ET
- Fiscal Q1 2026 results conference call
- Earnings call date
- February 5, 2026
- Fiscal Q1 2026 results release and call
- Replay start time
- 11:00 a.m. ET
- Webcast replay availability on February 5, 2026
- Replay duration
- 1 year
- Archived earnings call webcast on investor website
Previous Earnings date Reports
-
Set Q4 and full-year 2025 results date and access details for call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal first quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 5, 2026.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on February 5, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations | Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.